DNA-based vaccine against West Nile virus on the anvilNovember 4th, 2008 - 5:23 pm ICT by ANI
Washington, Nov 4 (ANI): Researchers at the Fraunhofer Institute for Cell Therapy and Immunology IZI in Leipzig are developing a DNA-based vaccine against the dreaded West Nile virus (WNV), which can be transmitted from animals to humans.
The speacial feature of this vaccine is that it is also effective after onset of the disease, for it has therapeutic properties.
In this type of vaccine, DNA molecules known as plasmids extracted from the pathogen are used for inoculation, instead of the whole virus. They contain the genetic code for the antigens that stimulate the body to produce antibodies. We can thus replicate the viruss natural infection route without actually triggering the disease, said Dr. Matthias Giese, the IZIs head of vaccine development.
Traditional methods of vaccination involve injecting a dead or weakened form of the pathogen into the patients body, which responds by producing the corresponding antibodies and developing immunity to the disease.
An alternative is to inject a serum that already contains these antibodies. Such vaccines are merely preventive.
By contrast with live vaccines, which carry a risk of provoking the disease, DNA vaccines are absolutely biologically safe.
Moreover, they activate all existing defence mechanisms in the body, are cheap to produce and can be stored without a refrigerator which makes them ideal for use in subtropical and tropical climates.
Since the human immune system is very similar to that of other mammals, we are developing a cross-species vaccine for use in both veterinary and human medicine. And unlike conventional vaccines, DNA vaccines can be used both as prophylactics and as therapeutics, i.e. in cases where the disease is already present, said Dr. Matthias Giese, citing the further benefits.
The WNV vaccine has already passed initial tests. Giese expects the laboratory research to be completed by the end of 2009.
After that, another 3 years or so will be needed for the approval procedure including clinical trials.
Then, it is hoped, the worlds first therapeutic WNV vaccine will be ready for market. (ANI)
- DNA vaccine to be equally effective after onset of disease - Nov 04, 2008
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Alternatives to antibiotics in sight - Jun 09, 2011
- Swine flu spread much wider than suspected - Jun 09, 2011
- Vaccines to boost immunity where it counts - Jan 23, 2012
- Soon, nasal spray vaccines to curb flu - Apr 12, 2011
- Once-in-a-lifetime flu jab that fights off all strains to be available 'within 5yrs' - Nov 16, 2010
- Breakthrough opens way for curing auto-immune disease - Mar 13, 2012
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Will a female birth control vaccine work? - Mar 13, 2011
- One-time jab to protect against all flu strains - Nov 16, 2010
- Rabies vaccine offers hope for AIDS vaccine - Dec 15, 2009
- Poor sleep hits potency of vaccines - Aug 02, 2012
- Oral vaccines are 'alternative to jab' - Feb 11, 2011
- Virus-like particle vaccine could offer protection against chikungunya virus - Jan 29, 2010
Tags: antigens, conventional vaccines, defence mechanisms, dna molecules, dna vaccines, fraunhofer institute, genetic code, human immune system, human medicine, initial tests, inoculation, izi, laboratory research, plasmids, speacial feature, therapeutic properties, tropical climates, vaccine development, west nile virus, wnv